157 related articles for article (PubMed ID: 25717260)
1. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.
Bockmann JH; Dandri M; Lüth S; Pannicke N; Lohse AW
World J Gastroenterol; 2015 Feb; 21(7):2214-9. PubMed ID: 25717260
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure.
Fujiwara K; Yasui S; Yokosuka O
World J Gastroenterol; 2015 Sep; 21(36):10485-6. PubMed ID: 26420977
[TBL] [Abstract][Full Text] [Related]
3. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.
Philips CA; Sarin SK
World J Gastroenterol; 2014 Nov; 20(43):16037-52. PubMed ID: 25473156
[TBL] [Abstract][Full Text] [Related]
4. Successful Living-Donor Liver Transplant for Fulminant Hepatitis in a Heart Recipient.
Yang PC; Ho CM; Chou NK; Wang SS; Wu YM; Ho MC; Hu RH; Lee PH
Exp Clin Transplant; 2015 Aug; 13(4):369-70. PubMed ID: 24650356
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy for hepatitis B virus associated hepatic failure.
Wang YM; Tang YZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
[TBL] [Abstract][Full Text] [Related]
6. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.
Ha JM; Sohn W; Cho JY; Pyo JH; Choi K; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Paik YH
Clin Mol Hepatol; 2015 Sep; 21(3):232-41. PubMed ID: 26523268
[TBL] [Abstract][Full Text] [Related]
7. [Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
Dumortier J; Durupt S; Chevallier M; Trépo C; Zoulim F
Gastroenterol Clin Biol; 1997; 21(12):982-6. PubMed ID: 9587563
[TBL] [Abstract][Full Text] [Related]
8. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure.
Chen EQ; Zeng F; Zhou LY; Tang H
World J Gastroenterol; 2015 Nov; 21(42):11964-73. PubMed ID: 26576085
[TBL] [Abstract][Full Text] [Related]
9. Management of acute hepatitis B and reactivation of hepatitis B.
Jindal A; Kumar M; Sarin SK
Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.
Saha BK; Mahtab MA; Akbar SMF; Noor-E-Alam SM; Mamun AA; Hossain SMS; Alam MA; Moben AL; Khondaker FA; Chowdhury FI; Raihan R; Rahman S; Choudhury AK;
Hepatol Int; 2017 Nov; 11(6):540-546. PubMed ID: 28840583
[TBL] [Abstract][Full Text] [Related]
12. Acute-on-chronic liver failure in chronic hepatitis B: an update.
Zhao RH; Shi Y; Zhao H; Wu W; Sheng JF
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):341-350. PubMed ID: 29334786
[TBL] [Abstract][Full Text] [Related]
13. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Wong VW; Chan HL
J Gastroenterol Hepatol; 2009 Jul; 24(7):1179-86. PubMed ID: 19682192
[TBL] [Abstract][Full Text] [Related]
14. Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B.
Kim H; Kwon JH; Kim YH; Nam SW; Lee JY; Jang JW
Clin Mol Hepatol; 2018 Dec; 24(4):430-435. PubMed ID: 29172397
[TBL] [Abstract][Full Text] [Related]
15. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
Chen CH; Lin CL; Hu TH; Hung CH; Tseng PL; Wang JH; Chang JY; Lu SN; Chien RN; Lee CM
J Hepatol; 2014 Jun; 60(6):1127-34. PubMed ID: 24583247
[TBL] [Abstract][Full Text] [Related]
16. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt HE; Ouyang DL; Keeffe EB
Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial.
Huang L; Li J; Yan J; Sun J; Zhang X; Wu M; Yan Y
J Viral Hepat; 2013 May; 20(5):336-42. PubMed ID: 23565616
[TBL] [Abstract][Full Text] [Related]
18. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
Fujiwara K; Yasui S; Okitsu K; Yonemitsu Y; Oda S; Yokosuka O
J Gastroenterol; 2010 Dec; 45(12):1255-62. PubMed ID: 20614156
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
Wang L; Chen H; Fan C; Gong Z
J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
[TBL] [Abstract][Full Text] [Related]
20. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
